Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Creative Medical Technology Holdings (CELZ) Gains from Investment Securities (2016 - 2025)

Creative Medical Technology Holdings has reported Gains from Investment Securities over the past 7 years, most recently at $11183.0 for Q3 2025.

  • Quarterly Gains from Investment Securities changed 0.0% to $11183.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $11183.0 through Sep 2025, changed 0.0% year-over-year, with the annual reading at $1.0 for FY2025, 99.99% down from the prior year.
  • Gains from Investment Securities was $11183.0 for Q3 2025 at Creative Medical Technology Holdings, roughly flat from $11183.0 in the prior quarter.
  • Over five years, Gains from Investment Securities peaked at $23.0 million in Q2 2022 and troughed at $11183.0 in Q3 2022.
  • The 5-year median for Gains from Investment Securities is $11183.0 (2022), against an average of $2.2 million.
  • Peak annual rise in Gains from Investment Securities hit 0.0% in 2023, while the deepest fall reached 99.95% in 2023.
  • Tracing CELZ's Gains from Investment Securities over 5 years: stood at $989346.0 in 2021, then crashed by 98.87% to $11183.0 in 2022, then changed by 0.0% to $11183.0 in 2023, then changed by 0.0% to $11183.0 in 2024, then changed by 0.0% to $11183.0 in 2025.
  • According to Business Quant data, Gains from Investment Securities over the past three periods came in at $11183.0, $11183.0, and $11183.0 for Q3 2025, Q2 2025, and Q3 2024 respectively.